instagram-xl.png
youtube-4-xxl.png

Become a FREE MEMBER

Contact us

  • ABOUT US

    • OUR ACTIVITIES
    • LARI ALLENBICK AWARD
    • HISTORY
    • FABRY AUSTRALIA COMMITTEE
    • PHARMACUETICAL INDUSTRY
    • MEDICAL ADVISORY COMMITTEE

  • WHAT IS FABRY

    • SIGNS & SYMPTOMS
    • TESTING & DIAGNOSIS
    • HOW IS FABRY INHERITED
    • RESOURCES AND LINKS

  • FABRY CLINICS

    • RESEARCH
    • TREATMENT & MANAGEMENT

  • GET INVOLVED

    • MEMBERSHIP
    • FUNDRAISING
    • ONLINE STORE
    • CONTACT YOUR LOCAL MP

  • NEWS/EVENTS

    • AWARENESS MONTH

  • DONATE

  • More

    Press Releases

    amicus.png

    PRESS RELEASE: Fabry Australia Amicus Therapeutics Announces Reimbursement of Galafold® (migalastat) for Treatment of Fabry Disease in Australia

    +61 (0)412 462 732

    admin@fabry.com.au

    Fabry Australia Inc.  |  ABN 70 053 079 595  | Registered Number A0029817E
    Terms & Conditions
    ACNC-Registered-Charity-Logo_RGB.png

    Privacy Policy